Sierra Oncology, Inc.
Methods of Treating Cancer with Chk1 Inhibitors

Last updated:

Abstract:

Disclosed herein are methods of treatment by administering SRA737 as a monotherapy or in a combination therapy that is useful for treating patients with cancer.

Status:
Application
Type:

Utility

Filling date:

26 Mar 2020

Issue date:

16 Jun 2022